The money is intended to to fuel European biotech startups.
A venture capital firm in the Netherlands -- backed by some big names in Big Pharma -- has raised $95 million in a new fund to fuel European biotech startups.
The Dutch VC firm, called BioGeneration Ventures (BGV), plans to sink cash into seed-stage companies developing therapeutics, medical devices, and diagnostics. Managing partner Edward van Wezel said the fund has no particular area of focus, but will likely keep an eye out for immuno-oncology and heart disease drugs.
